We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Micro C works with the company’s OXOS Platform for image management, telehealth collaboration and delivery of artificial intelligence-based diagnostics. Read More
The FDA’s Breakthrough Device designation is intended to give patients more timely access to new devices by expediting their development and review. Read More
The data provide “the first comparative evidence” that the Imbruvica combination has the potential to extend time to disease progression vs. standard therapy,” the trial’s lead investigator said. Read More
The implanted device stimulates the patient’s spinal cord to provide pain relief, adjusting the stimulation to maintain each patient’s optimal dose. Read More
Trial investigator Ali Taher said the findings demonstrate that Reblozyl sustained elevated hemoglobin levels in most patients “regardless of their baseline hemoglobin status.” Read More
The catheter-based device is delivered through the femoral artery, temporarily inflating a soft balloon in the aorta to redirect blood flow toward the upper body. Read More